Learn more in our Press Release here: To view or add a comment, sign in Exciting to see continued growth in the Radiopharma ecosystem
Activating smoothened mutations in sporadic basal-cell carcinoma
IVIM results of 26.54% slightly exceed this, though direct comparisons between clinical trials and real-world observational studies require caution due to differences in patient selection, adherence monitoring, and measurement methods
Perhaps we should accept this since the progression of kidney disease in kidney transplant has many other facets including immunological factors, such that even RAS blockade may not be favorable (Hiremath et al, AJKD 2017)
This can improve their overall quality of life, allowing them to engage more fully in their daily activities without the constant burden of pain or excessive bleeding
Conversely, research examining Dihexa's effects on traumatic brain injury recovery employed administration only on alternating daysa 48-hour interval protocol